RxDoctor Payments Data

Alicia Conway, PA

Physician Assistant · Turlock, CANPI 1689140485

Payments from drug & device makers

$1,451in general payments, 2019–2025

Across 64 payments — averaging $22.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Corcept Therapeutics$278
  • Novo Nordisk$255
  • AstraZeneca$219
  • Lilly USA, LLC$140
  • Amgen$105
  • Novartis$88
  • plus $367 from 10 others

What the payments were for

  • Food & beverage$1,41998%
  • Education$322%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,451 in reported general payments places this provider in the 75th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Medicare billing

Part B allowed, 2024
$15,029
Medicare patients
129
Services billed
142

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JanumetSitagliptin Phos/Metformin Hcl49$36,351
JanuviaSitagliptin Phosphate32$35,716
OzempicSemaglutide18$32,321
JardianceEmpagliflozin25$28,997
FarxigaDapagliflozin Propanediol21$17,445
EliquisApixaban20$11,382
XareltoRivaroxaban14$10,940
VascepaIcosapent Ethyl21$7,198
Icosapent Ethyl13$4,241
Atorvastatin Calcium321$3,682
SymbicortBudesonide/Formoterol Fumarate13$3,056
Lantus SolostarInsulin Glargine,hum.Rec.Anlog33$2,893
Levothyroxine Sodium171$2,888
Losartan Potassium221$2,251
Gabapentin169$1,932

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$255$32,32118 claims
Boehringer IngelheimJardiance$39$28,99725 claims
AstraZenecaFarxiga, Symbicort$219$20,50134 claims
Johnson & JohnsonXarelto$42$10,94014 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Turlock

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →